InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by MILESON GLENNA, Chief Financial Officer. Director active across 1 companies, notably Athira Pharma, Inc.. Cumulatively, 6 reports have been logged. The latest transaction was disclosed on 18 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
€11,6021,721 shares@ €6.741311.8% of flow
Common Stock
SEC:0001209191-22-039342:0·
€29,3443,000 shares@ €9.781229.9% of flow
Common Stock
SEC:0001209191-22-024219:0·
€10,288931 shares@ €11.050135.9% of flow
Common Stock
SEC:0001209191-22-002218·
€10,288931 shares@ €11.050110.5% of flow
Common Stock
SEC:0001209191-22-002218:0·
€18,3701,554 shares@ €11.82164.1% of flow
Common Stock
SEC:0001209191-21-039627·
€18,3701,554 shares@ €11.82118.7% of flow
Common Stock
SEC:0001209191-21-039627:0·
6 of 6 declarations
About MILESON GLENNA
Glenna Mileson is the Chief Financial Officer at Athira Pharma, Inc. She is responsible for the company's financial management, including budgeting and financial strategy. Her role is crucial in ensuring the financial health of the company and supporting its growth in the pharmaceutical sector.
